These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746 [TBL] [Abstract][Full Text] [Related]
5. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors. Part 2. The impact of bridging groups at position C-2. Lee HY; Chang JY; Nien CY; Kuo CC; Shih KH; Wu CH; Chang CY; Lai WY; Liou JP J Med Chem; 2011 Dec; 54(24):8517-25. PubMed ID: 22060033 [TBL] [Abstract][Full Text] [Related]
6. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization. Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164 [TBL] [Abstract][Full Text] [Related]
7. 2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors. Chuang HY; Chang JY; Lai MJ; Kuo CC; Lee HY; Hsieh HP; Chen YJ; Chen LT; Pan WY; Liou JP ChemMedChem; 2011 Mar; 6(3):450-6. PubMed ID: 21360819 [TBL] [Abstract][Full Text] [Related]
8. 10-(2-oxo-2-phenylethylidene)-10H-anthracen-9-ones as highly active antimicrotubule agents: synthesis, antiproliferative activity, and inhibition of tubulin polymerization. Prinz H; Schmidt P; Böhm KJ; Baasner S; Müller K; Unger E; Gerlach M; Günther EG J Med Chem; 2009 Mar; 52(5):1284-94. PubMed ID: 19220018 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents. Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271 [TBL] [Abstract][Full Text] [Related]
10. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles. Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of benzils related to combretastatin A-4. Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509 [TBL] [Abstract][Full Text] [Related]
13. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents. O'Boyle NM; Carr M; Greene LM; Bergin O; Nathwani SM; McCabe T; Lloyd DG; Zisterer DM; Meegan MJ J Med Chem; 2010 Dec; 53(24):8569-84. PubMed ID: 21080725 [TBL] [Abstract][Full Text] [Related]
15. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41. Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation of 1,1-diarylethylenes as a novel class of antimitotic agents. Hamze A; Giraud A; Messaoudi S; Provot O; Peyrat JF; Bignon J; Liu JM; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M ChemMedChem; 2009 Nov; 4(11):1912-24. PubMed ID: 19790205 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs. Fürst R; Zupkó I; Berényi A; Ecker GF; Rinner U Bioorg Med Chem Lett; 2009 Dec; 19(24):6948-51. PubMed ID: 19879758 [TBL] [Abstract][Full Text] [Related]
18. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues. Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of thiophene analogues of chalcones. Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234 [TBL] [Abstract][Full Text] [Related]
20. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity. Simoni D; Romagnoli R; Baruchello R; Rondanin R; Grisolia G; Eleopra M; Rizzi M; Tolomeo M; Giannini G; Alloatti D; Castorina M; Marcellini M; Pisano C J Med Chem; 2008 Oct; 51(19):6211-5. PubMed ID: 18783207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]